Shopping Cart
- Remove All
- Your shopping cart is currently empty
The IC50s of DC4SMe on Ramos, Namalwa and HL60 / s cancer cells were 1.9 nM, 2.9 nM and 1.8 nM, respectively. DC4SMe can be used for targeted therapy of tumors. DC4SMe is a phosphate prodrug of the cytotoxic DNA alkylating agent DC4 and can be used in the synthesis of antibody-drug conjugates (ADC).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 2.726 € | 10-14 weeks | |
50 mg | 3.591 € | 10-14 weeks | |
100 mg | 4.940 € | 10-14 weeks |
Description | The IC50s of DC4SMe on Ramos, Namalwa and HL60 / s cancer cells were 1.9 nM, 2.9 nM and 1.8 nM, respectively. DC4SMe can be used for targeted therapy of tumors. DC4SMe is a phosphate prodrug of the cytotoxic DNA alkylating agent DC4 and can be used in the |
In vitro | Phosphate prodrugs may be a suitable choice for effector ADCs that do not have sufficient water solubility or stability. |
Molecular Weight | 764.21 |
Formula | C35H31ClN5O7PS2 |
Cas No. | 615538-47-1 |
Relative Density. | 1.600 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.